Cornerstone Capital Management Holdings LLC. Has $4.34 Million Holdings in Zimmer Biomet Holdings Inc (ZBH)
Cornerstone Capital Management Holdings LLC. cut its holdings in Zimmer Biomet Holdings Inc (NYSE:ZBH) by 2.8% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 37,030 shares of the medical equipment provider’s stock after selling 1,068 shares during the period. Cornerstone Capital Management Holdings LLC.’s holdings in Zimmer Biomet were worth $4,335,000 as of its most recent SEC filing.
A number of other institutional investors have also bought and sold shares of ZBH. Bronfman E.L. Rothschild L.P. grew its holdings in shares of Zimmer Biomet by 25.3% during the second quarter. Bronfman E.L. Rothschild L.P. now owns 827 shares of the medical equipment provider’s stock worth $106,000 after buying an additional 167 shares during the last quarter. FNY Managed Accounts LLC purchased a new position in shares of Zimmer Biomet during the third quarter worth about $117,000. BB&T Investment Services Inc. purchased a new position in shares of Zimmer Biomet during the second quarter worth about $144,000. Sandy Spring Bank grew its holdings in shares of Zimmer Biomet by 5.4% during the second quarter. Sandy Spring Bank now owns 1,288 shares of the medical equipment provider’s stock worth $166,000 after buying an additional 66 shares during the last quarter. Finally, Penserra Capital Management LLC grew its holdings in shares of Zimmer Biomet by 13.0% during the second quarter. Penserra Capital Management LLC now owns 1,456 shares of the medical equipment provider’s stock worth $186,000 after buying an additional 168 shares during the last quarter. Institutional investors own 86.24% of the company’s stock.
Shares of Zimmer Biomet Holdings Inc (ZBH) traded up $2.42 during trading on Friday, hitting $115.24. The company had a trading volume of 2,125,344 shares, compared to its average volume of 1,250,446. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.47 and a quick ratio of 0.78. Zimmer Biomet Holdings Inc has a 1 year low of $100.87 and a 1 year high of $133.49. The firm has a market cap of $23,332.99, a P/E ratio of 14.28, a P/E/G ratio of 1.79 and a beta of 1.15.
Zimmer Biomet (NYSE:ZBH) last issued its quarterly earnings results on Wednesday, November 1st. The medical equipment provider reported $1.72 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $1.74 by ($0.02). The business had revenue of $1.82 billion during the quarter, compared to analyst estimates of $1.83 billion. Zimmer Biomet had a net margin of 8.36% and a return on equity of 16.29%. The company’s revenue was down .8% on a year-over-year basis. During the same quarter last year, the firm posted $1.79 earnings per share. equities research analysts expect that Zimmer Biomet Holdings Inc will post 8.03 earnings per share for the current fiscal year.
A number of brokerages have weighed in on ZBH. BMO Capital Markets reaffirmed a “buy” rating and issued a $142.00 price objective on shares of Zimmer Biomet in a report on Tuesday, December 12th. Gabelli began coverage on Zimmer Biomet in a report on Thursday, August 24th. They issued a “buy” rating and a $142.00 price objective on the stock. SunTrust Banks reaffirmed a “buy” rating and issued a $136.00 price objective on shares of Zimmer Biomet in a report on Monday, October 2nd. Morgan Stanley lowered their price objective on Zimmer Biomet from $146.00 to $136.00 and set an “overweight” rating on the stock in a report on Thursday, November 2nd. Finally, Stifel Nicolaus reaffirmed a “hold” rating and issued a $120.00 price objective on shares of Zimmer Biomet in a report on Friday, November 3rd. Four research analysts have rated the stock with a sell rating, seven have given a hold rating, fourteen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus target price of $134.05.
ILLEGAL ACTIVITY NOTICE: “Cornerstone Capital Management Holdings LLC. Has $4.34 Million Holdings in Zimmer Biomet Holdings Inc (ZBH)” was reported by Watch List News and is the sole property of of Watch List News. If you are accessing this story on another website, it was stolen and reposted in violation of U.S. & international copyright legislation. The legal version of this story can be viewed at https://www.watchlistnews.com/cornerstone-capital-management-holdings-llc-has-4-34-million-holdings-in-zimmer-biomet-holdings-inc-zbh/1769863.html.
About Zimmer Biomet
Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.
Receive News & Ratings for Zimmer Biomet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet and related companies with Analyst Ratings Network's FREE daily email newsletter.